John Hopkins Cancer Center

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Childhood cancers1 trial
• Myelodysplastic syndromes1 trial

Phase

• Phase 11 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Institut de Recherches Internationales Servier2 trials

Running trials

• Active, not recruiting

  Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)

  NCT04164901· Phase 3· Institut de Recherches Internationales Servier· Source

• Recruiting

  Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

  NCT02074839· Phase 1· Institut de Recherches Internationales Servier· Source

  Contact: Institut de Recherches Internationales Servier Clinical Studies Department